Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2001 Jan;23(1):54-6.
doi: 10.1097/00043426-200101000-00013.

Treatment of Langerhans Cell Histiocytosis With Pamidronate

Affiliations
Case Reports

Treatment of Langerhans Cell Histiocytosis With Pamidronate

R P Farran et al. J Pediatr Hematol Oncol. .

Abstract

A 14-year-old boy with longstanding multisystem Langerhans cell histiocytosis (LCH) had multifocal bone pain unresponsive to chemotherapy, corticosteroids, anti-inflammatories, and narcotic analgesics. He responded to two cycles of intravenous pamidronate, each 90 mg per day on three consecutive days. Two subsequent episodes of deterioration also responded to treatment. The pathophysiology of his bone pain and the likely mechanisms of biphosphonate action are discussed, with emphasis on the molecular and cellular basis of LCH.

Similar articles

See all similar articles

Cited by 15 articles

See all "Cited by" articles

Publication types

LinkOut - more resources

Feedback